AGADA Biosciences: Funding, Investors & Team (Sep 2026)
AGADA Biosciences is an accelerated drug development form. They offer to develop standard operating procedures. They provide advice on human trial design, regulatory writing, biomarker method development, qualification, and validation.
AGADA Biosciences has raised $420k across 1 funding round on record, the most recent an undisclosed round of $420k announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AGADA Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
AGADA Biosciences Funding Rounds
AGADA Biosciences Founders and Leadership Team
Contact details for the AGADA Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →AGADA Biosciences Funding Compared to Other Biotechnology Startups
AGADA Biosciences' latest round of $420k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AGADA Biosciences in Biotechnology and Halifax
Companies Similar to AGADA Biosciences
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
AGADA Biosciences Funding FAQs
What does AGADA Biosciences do?
AGADA Biosciences is an accelerated drug development form. They offer to develop standard operating procedures. They provide advice on human trial design, regulatory writing, biomarker method development, qualification, and validation.
How much funding has AGADA Biosciences raised?
AGADA Biosciences has raised $420k across 1 round on record. The most recent is an undisclosed round of $420k announced in Mar 2026.
When did AGADA Biosciences last raise funding?
AGADA Biosciences' most recent funding round on record is an undisclosed round of $420k, announced in Mar 2026.
Who founded AGADA Biosciences?
FundedIQ lists Amanda Mullen (Founder) at AGADA Biosciences.
Where is AGADA Biosciences headquartered?
AGADA Biosciences is based in Halifax, Nova Scotia, Canada.
How many employees does AGADA Biosciences have?
AGADA Biosciences is in the 11-50 employee band.
How does AGADA Biosciences' funding compare to other Biotechnology startups?
AGADA Biosciences' latest round of $420k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AGADA Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AGADA Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.